These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 34768962)

  • 21. Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease.
    Francardo V; Recchia A; Popovic N; Andersson D; Nissbrandt H; Cenci MA
    Neurobiol Dis; 2011 Jun; 42(3):327-40. PubMed ID: 21310234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High frequency stimulation of the subthalamic nucleus improves speed of locomotion but impairs forelimb movement in Parkinsonian rats.
    Vlamings R; Visser-Vandewalle V; Koopmans G; Joosten EA; Kozan R; Kaplan S; Steinbusch HW; Temel Y
    Neuroscience; 2007 Sep; 148(3):815-23. PubMed ID: 17706885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of unilateral lesion of the nigrostriatal dopamine pathway on survival and neurochemistry of parafascicular nucleus neurons in the rat--evaluation of time-course and LGR8 expression.
    Sedaghat K; Finkelstein DI; Gundlach AL
    Brain Res; 2009 May; 1271():83-94. PubMed ID: 19328193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progressive and extensive dopaminergic degeneration induced by convection-enhanced delivery of 6-hydroxydopamine into the rat striatum: a novel rodent model of Parkinson disease.
    Oiwa Y; Sanchez-Pernaute R; Harvey-White J; Bankiewicz KS
    J Neurosurg; 2003 Jan; 98(1):136-44. PubMed ID: 12546362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electroacupuncture Therapy Ameliorates Motor Dysfunction via Brain-Derived Neurotrophic Factor and Glial Cell Line-Derived Neurotrophic Factor in a Mouse Model of Parkinson's Disease.
    Pak ME; Ahn SM; Jung DH; Lee HJ; Ha KT; Shin HK; Choi BT
    J Gerontol A Biol Sci Med Sci; 2020 Mar; 75(4):712-721. PubMed ID: 31644786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurodegeneration and glial morphological changes are both prevented by TRPM2 inhibition during the progression of a Parkinson's disease mouse model.
    Ferreira AFF; Ulrich H; Feng ZP; Sun HS; Britto LR
    Exp Neurol; 2024 Jul; 377():114780. PubMed ID: 38649091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymphocytes reduce nigrostriatal deficits in the 6-hydroxydopamine mouse model of Parkinson's disease.
    Ip CW; Beck SK; Volkmann J
    J Neural Transm (Vienna); 2015 Dec; 122(12):1633-43. PubMed ID: 26290125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of intrastriatal single injection of GDNF on the nigrostriatal dopaminergic system in hemiparkinsonian rats: behavioral and histological studies using two different dosages.
    Aoi M; Date I; Tomita S; Ohmoto T
    Neurosci Res; 2000 Apr; 36(4):319-25. PubMed ID: 10771110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Time course of dopamine neuron loss and glial response in the 6-OHDA striatal mouse model of Parkinson's disease.
    Stott SRW; Barker RA
    Eur J Neurosci; 2014 Mar; 39(6):1042-1056. PubMed ID: 24372914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for cross-hemispheric preconditioning in experimental Parkinson's disease.
    Weilnau JN; Carcella MA; Miner KM; Bhatia TN; Hutchison DF; Pant DB; Nouraei N; Leak RK
    Brain Struct Funct; 2018 Apr; 223(3):1255-1273. PubMed ID: 29103154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of GAP-43 protein and mRNA in nigrostriatal dopaminergic neurons after the partial destruction of dopaminergic terminals with intrastriatal 6-hydroxydopamine.
    Iwata SI; Nomoto M; Fukuda T
    Synapse; 2001 Jan; 39(1):16-22. PubMed ID: 11071705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of graded 6-Hydroxydopamine unilateral lesion in medial forebrain bundle of mice.
    Cui J; Zhao D; Xu M; Li Z; Qian J; Song N; Wang J; Xie J
    Sci Rep; 2024 Feb; 14(1):3721. PubMed ID: 38355892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative study of the neurotrophic effects elicited by VEGF-B and GDNF in preclinical in vivo models of Parkinson's disease.
    Yue X; Hariri DJ; Caballero B; Zhang S; Bartlett MJ; Kaut O; Mount DW; Wüllner U; Sherman SJ; Falk T
    Neuroscience; 2014 Jan; 258():385-400. PubMed ID: 24291725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of a new low-dose 6-hydroxydopamine model of Parkinson's disease in rat.
    Penttinen AM; Suleymanova I; Albert K; Anttila J; Voutilainen MH; Airavaara M
    J Neurosci Res; 2016 Apr; 94(4):318-28. PubMed ID: 26762168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adeno-associated viral delivery of GDNF promotes recovery of dopaminergic phenotype following a unilateral 6-hydroxydopamine lesion.
    McGrath J; Lintz E; Hoffer BJ; Gerhardt GA; Quintero EM; Granholm AC
    Cell Transplant; 2002; 11(3):215-27. PubMed ID: 12075987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Further Characterization of Intrastriatal Lipopolysaccharide Model of Parkinson's Disease in C57BL/6 Mice.
    Deng I; Corrigan F; Garg S; Zhou XF; Bobrovskaya L
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the behavioural and histological characteristics of the 6-OHDA and α-synuclein rat models of Parkinson's disease.
    Decressac M; Mattsson B; Björklund A
    Exp Neurol; 2012 May; 235(1):306-15. PubMed ID: 22394547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD200-CD200R dysfunction exacerbates microglial activation and dopaminergic neurodegeneration in a rat model of Parkinson's disease.
    Zhang S; Wang XJ; Tian LP; Pan J; Lu GQ; Zhang YJ; Ding JQ; Chen SD
    J Neuroinflammation; 2011 Nov; 8():154. PubMed ID: 22053982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucagon-like peptide 1 receptor stimulation reverses key deficits in distinct rodent models of Parkinson's disease.
    Harkavyi A; Abuirmeileh A; Lever R; Kingsbury AE; Biggs CS; Whitton PS
    J Neuroinflammation; 2008 May; 5():19. PubMed ID: 18492290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary 8-OHdG elevations in a partial lesion rat model of Parkinson's disease correlate with behavioral symptoms and nigrostriatal dopaminergic depletion.
    Kikuchi Y; Yasuhara T; Agari T; Kondo A; Kuramoto S; Kameda M; Kadota T; Baba T; Tajiri N; Wang F; Tayra JT; Liang H; Miyoshi Y; Borlongan CV; Date I
    J Cell Physiol; 2011 May; 226(5):1390-8. PubMed ID: 20945350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.